Hong Kong Disneyland Resort

21 March 2015

We had a wonderful time attending a one-day staff retreat at the Hong Kong Disneyland Resort, including a workshop, Effective Communication through DISC, led by Ms. Gentiana Cheung, a professional consultant from the School of Hotel and Tourism Management of The Chinese University of Hong Kong.

Our Past Events

Eagle IP Celebrates 20th Anniversary, Reflecting on Two Decades of Excellence

21 May 2025

Eagle IP is Coming Back to LSPN in Boston!

24 April 2025

AIPLA Women in IP Global Networking Event in Hong Kong

3 April 2025

Talk at Hong Kong Christian Service

31 October 2024

Talk for HKUST Entrepreneurship 101 Training Program

31 October 2024

IP Training Programme on patent commercialization and technology transfer

8 October 2024

Recommended Insights

China Divisional Practice

17 June 2019

China allows the filing of divisional applications but under specific circumstances. Most importantly, divisional applications can usually only be filed voluntarily during the prosecution of the original parent application. Once the parent application is granted or withdrawn, no additional voluntary divisional applications may be filed. However, divisionals can be filed to pursue subject matter not […]

China’s Newest Examination Guidelines: Inventive Step for Biological / Life Science Inventions (Part III)

30 April 2021

This is Part III of a three-part series summarizing the Examination Guidelines that were released by the CNIPA on January 15, 2021, one year to the date of Phase 1 of the US and China Economic and Trade Agreement. That agreement included specific provisions where China "shall permit pharmaceutical patent applicants to rely on supplemental […]

2019 CHINA TOP 10 IP CASE: VALEO V. LUCAS, FUKE, & CHEN

8 June 2020

Every year in the spring The Supreme People’s Court of PRC announces its “Top 10 Intellectual Property (IP) cases” and “50 typical IP cases in Chinese courts” of the year. Although not having precedential weight, these cases serve as a reference and guide people's courts at all levels regarding their intellectual property trials. It’s always […]

China Top 10 Patent Re-Examination and Invalidation Cases of 2020 CNIPA Upholds Bayer’s Rivaroxaban Patent

9 June 2021

The development of China’s approach to patents, especially those in the pharmaceutical and biotech space, has been fascinating to watch. Those of us who have practiced in the area for a long time have been frustrated by the Chinese patent office’s overly strict rules regarding patentability (e.g., high data support standard and refusal to consider […]